Validity of a Smartphone App to Objectively Monitor Performance Outcomes in Degenerative Cervical Myelopathy: Preliminary Findings From a Longitudinal Observational Study
JMIR Neurotechnology · 2024
DOI: 10.2196/52832 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIR Neurotechnology, 2024. Verfasst von Alvaro Yanez Touzet und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences Faculty of Biology, Medicine and Health University of Manchester Manchester United Kingdom. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Developing new clinical measures for degenerative cervical myelopathy (DCM) is an AO Spine RECODE-DCM research priority. Difficulties detecting DCM, and changes in DCM, cause diagnostic and treatment delays in clinical settings and heightened costs in clinical trials due to elevated recruitment targets. Digital outcome measures can tackle these challenges due to their ability to measure disease remotely, repeatedly, and more economically.
Objective
The study aims to assess the validity of MoveMed, a battery of performance outcome measures performed using a smartphone app, in the measurement of DCM.
Methods
A prospective observational study in decentralized secondary care was performed in England, United Kingdom. Validity and risk of bias were assessed using criteria from the COSMIN (Consensus-Based Standards for the Selection of Health Measurement Instruments) manual. Each MoveMed outcome was compared with 2 patient-reported comparators, with a priori hypotheses of convergence or divergence tested against consensus thresholds. The primary outcome was the correlation coefficient between the MoveMed outcome and the patient-reported comparators. The secondary outcome was the percentage of correlations that aligned with the a priori hypotheses. The comparators used were the patient-derived modified Japanese Orthopaedic Association score and the World Health Organization Quality of Life Brief Version questionnaire. Thresholds for convergence or divergence were set at ≥0.3 for convergence, 0/
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medical Sciences Faculty of Biology, Medicine and Health University of Manchester Manchester United Kingdom.
- MoveMed Ltd Cambridge United Kingdom.
- Division of Science New York University Abu Dhabi Abu Dhabi United Arab Emirates.
- NYU Langone Health New York, NY United States.
- Icahn School of Medicine at Mount Sinai New York, NY United States.
- Department of Neurological Surgery University of California, Davis Davis, CA United States.
ORCID-Profile: Alvaro Yanez Touzet, Tatiana Houhou, Zerina Rahic, Ilya Laufer, Konstantinos Margetis, Allan R Martin, Nicolas Dea, Zoher Ghogawala, Misha Kapushesky, Mark R N Kotter, Benjamin M Davies
Zitieren
APA
Yanez Touzet, A., Houhou, T., Rahic, Z., Laufer, I., Margetis, K., Martin, A. R., Dea, N., Ghogawala, Z., Kapushesky, M., Kotter, M. R. N., Davies, B. M., & MoveMed (2024). Validity of a Smartphone App to Objectively Monitor Performance Outcomes in Degenerative Cervical Myelopathy: Preliminary Findings From a Longitudinal Observational Study. JMIR Neurotechnology. https://doi.org/10.2196/52832
Vancouver
Yanez Touzet A, Houhou T, Rahic Z, Laufer I, Margetis K, Martin AR, et al. Validity of a Smartphone App to Objectively Monitor Performance Outcomes in Degenerative Cervical Myelopathy: Preliminary Findings From a Longitudinal Observational Study. JMIR Neurotechnology. 2024. doi:10.2196/52832
BibTeX
@article{YanezTouzet2024,
author = {Yanez Touzet, Alvaro and Houhou, Tatiana and Rahic, Zerina and Laufer, Ilya and Margetis, Konstantinos and Martin, Allan R and Dea, Nicolas and Ghogawala, Zoher and Kapushesky, Misha and Kotter, Mark R N and Davies, Benjamin M and MoveMed, MoveMed},
title = {Validity of a Smartphone App to Objectively Monitor Performance Outcomes in Degenerative Cervical Myelopathy: Preliminary Findings From a Longitudinal Observational Study},
journal = {JMIR Neurotechnology},
year = {2024},
doi = {10.2196/52832}
}
EUVIMED